12 unknown. 12 Phase 2, 4 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Unknown 12 |
| Phase 1 | 4 | Unknown 4 |
| Phase 3 | 4 | Unknown 4 |
Follow Disease: new trials by email Literature Review of Disease trials Research Report on Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment Treatment-specific InSight, InSight - Sepsis, Severe Sepsis | Phase 2 | Unknown | Dascena | 51645 | 2022-04-01 | 2021-09-23 |
| Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study Aveed 750 MG in 3 ML IM Injection, Normal Saline 3 ML IM Injection - Muscle Atrophy, Surgery | Phase 2 / Phase 3 | Unknown | The Stone Research Foundation for Sports Medicine and Arthritis | 15 | 2020-05-08 | 2021-08-31 |
| Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT Decitabine, Busulfan (BU), Cyclophosphamide (CY) - Allogeneic Hematopoietic Stem Cell Transplantation, Conditions | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 122 | 2018-07-01 | 2018-07-24 |
| CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies Autologous CAR-T cells - Leukemia, Lymphoma | Phase 1 / Phase 2 | Unknown | Hebei Senlang Biotechnology Inc., Ltd. | 50 | 2017-08-29 | 2019-01-09 |
| Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22 anti-CD19/22-CAR vector-transduced T cells - Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission | Phase 1 / Phase 2 | Unknown | Chinese PLA General Hospital | 30 | 2017-08-01 | 2019-04-17 |
| Basiliximab Treating Interstitial Pneumonia of CADM Basiliximab, Calcineurin Inhibitors, Steroids - Lung; Disease, Interstitial, With Fibrosis, Dermatomyositis | Phase 2 | Unknown | RenJi Hospital | 100 | 2017-07-01 | 2017-06-20 |
| Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of AIR DNase™in Patients With Cystic Fibrosis Previously Treated With Pulmozyme® AIR DNase™ - Cystic Fibrosis | Phase 2 | Unknown | Protalix | 15 | 2016-05-01 | 2016-09-28 |
| Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome benralizumab, Placebo - Respiratory System Agents, Anti-Asthmatic Agents | Phase 2 / Phase 3 | Unknown | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | 2014-05-19 | 2022-02-08 |
| Dementia Early Recognition and Response in Primary Care Educational Dementia training - Dementia | Phase 2 / Phase 3 | Unknown | University College, London | 125 | 2009-07-01 | 2010-04-19 |
| A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma Temozolomide - Glioma | Phase 2 | Unknown | Kentuckiana Cancer Institute | 20 | 2009-01-01 | 2010-01-20 |
| Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease Endoscopic Mucosal Resection (EMR) - Chronic Constipation, Hirschsprung's Disease | Phase 1 / Phase 2 | Unknown | Massachusetts General Hospital | 50 | 2007-10-01 | 2008-05-05 |
| Use of Hair to Diagnose the Presence of Breast Cancer diagnosis of breast cancer by x-ray diffraction of hair - Breast Cancer | Phase 1 / Phase 2 | Unknown | Fermiscan Ltd | 2000 | 2006-12-01 | 2007-01-09 |
Breast Neoplasms (1) · Constipation (1) · Cystic Fibrosis (1) · Dementia (1) · Dermatomyositis (1) · Digestive System Diseases (1) · Eosinophilia (1) · Eosinophilic Esophagitis (1) · Genetic Diseases, Inborn (1) · Glioma (1) · Hematologic Diseases (1) · Hematologic Neoplasms (1) · Hirschsprung Disease (1) · Knee Injuries (1)
Pathological Conditions, Signs and Symptoms (12) · Pathologic Processes (11) · Neoplasms (4) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Neoplasms by Histologic Type (3) · Nervous System Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Hematologic Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms by Site (2)
Basiliximab (1) · Busulfan (1) · Calcineurin Inhibitors (1) · Cyclophosphamide (1) · Decitabine (1) · Endoscopic Mucosal Resection (1) · Injections, Intramuscular (1) · Saline Solution (1) · Steroids (1) · Temozolomide (1) · Testosterone Propionate (1) · benralizumab (1)
Chinese PLA General Hospital (1) · Dascena (1) · Fermiscan Ltd (1) · Hebei Senlang Biotechnology Inc., Ltd. (1) · Kentuckiana Cancer Institute (1) · Massachusetts General Hospital (1) · Nanfang Hospital, Southern Medical University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Protalix (1) · RenJi Hospital (1) · The Stone Research Foundation for Sports Medicine and Arthritis (1) · University College, London (1)
China (4) · United States (4) · Australia (1) · Israel (1) · United Kingdom (1)
Amy D Klion, M.D. (1) · Braden Kuo, MD (1) · Clarissa Foy, NP (1) · Einat Dekel, DVM (1) · Field F Willingham, MD, MPH (1) · Garrett C Zella, MD (1) · Jane Wilcock, MA(hons) MSc (1) · Leonel Rodriguez, MD (1) · Mani Vessal, Ph.D. (1) · Mari Mino-Kenudson, MD (1) · Peggy Lu, PhD & MD (1) · Phillip Yuile, MBBS, FRACR (1) · Qifa Liu (1) · Qingqing Mao, PhD (1) · Renato V LaRocca, MD (1)
PMID 20146803, PMID 24257429, PMID 32245502, PMID 35283330, PMID 40120806